AstraZeneca lung cancer drug delays disease by more than a year

LONDON (Reuters) - An experimental lung cancer pill from AstraZeneca delays disease progression by more than a year, according to new data presented at a medical meeting on Friday.

from

• غرد
• مشاركة
• إضافة